Price History
Feb 9, 2026 — Apr 4, 2026Investment Snapshot
- Piotroski F-Score 3/9 — signs of financial weakness
- Loss-making — negative ROE of -269.2%
- Revenue growing at 51% annually
Hinge Health, Inc. (HNGE) is a Technology company operating in Services-Computer Processing & Data Preparation, listed on the NYSE . Key value metrics: Piotroski F-Score 3 out of 9 .
Value Score
Key Metrics
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Hinge Health, Inc. — Fundamental Analysis Summary
On financial health, HNGE shows a weak Piotroski F-Score of 3/9, a signal of deteriorating financial health, and negative return on equity of -269.2% (sector average: -3.1%), and elevated leverage with a debt-to-equity ratio of 1.74.
StockPik's composite Value Score for HNGE is 47/100 — reflecting current market or financial concerns. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
HNGE reports a high gross margin of 76.5% (sector average: 41.3%) and a negative operating margin of -125.7%.
HNGE shows revenue growing at 51% year-over-year, with earnings declining at 4,327%.